These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35633951)

  • 1. The Covert Surge: Murine Bile Acid Levels Are Associated With Pruritus in Pediatric Autoimmune Sclerosing Cholangitis.
    Meinel K; Szabo D; Dezsofi A; Pohl S; Strini T; Greimel T; Aguiriano-Moser V; Haidl H; Wagner M; Schlagenhauf A; Jahnel J
    Front Pediatr; 2022; 10():903360. PubMed ID: 35633951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders.
    Kremer AE; Gonzales E; Schaap FG; Oude Elferink RP; Jacquemin E; Beuers U
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):530-5. PubMed ID: 26628447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
    Kremer AE; van Dijk R; Leckie P; Schaap FG; Kuiper EM; Mettang T; Reiners KS; Raap U; van Buuren HR; van Erpecum KJ; Davies NA; Rust C; Engert A; Jalan R; Oude Elferink RP; Beuers U
    Hepatology; 2012 Oct; 56(4):1391-400. PubMed ID: 22473838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum autotaxin levels correlate with the severity of pruritus in intrahepatic cholestasis of pregnancy.
    Süzen Çaypınar S; Oğlak SC; Behram M; Gedik Özköse Z; Sezer S; Karakaş S
    J Obstet Gynaecol Res; 2022 Dec; 48(12):3093-3102. PubMed ID: 36164271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases.
    Wunsch E; Krawczyk M; Milkiewicz M; Trottier J; Barbier O; Neurath MF; Lammert F; Kremer AE; Milkiewicz P
    Sci Rep; 2016 Aug; 6():30847. PubMed ID: 27506882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
    Baumann U; Sturm E; Lacaille F; Gonzalès E; Arnell H; Fischler B; Jørgensen MH; Thompson RJ; Mattsson JP; Ekelund M; Lindström E; Gillberg PG; Torfgård K; Soni PN
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101751. PubMed ID: 34182185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characteristics of neonatal cholestasis induced by citrin deficiency.
    Wang JS; Wang XH; Zheng YJ; Fu HY; Chen R; Lu Y; Fang LJ; Saheki T; Kobayashi K
    World J Gastroenterol; 2012 Oct; 18(39):5601-7. PubMed ID: 23112554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis and Management of Pruritus in PBC and PSC.
    Kremer AE; Namer B; Bolier R; Fischer MJ; Oude Elferink RP; Beuers U
    Dig Dis; 2015; 33 Suppl 2():164-75. PubMed ID: 26641452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Bile Acid Profiling and Mixed Model Analysis Reveal Biomarkers Associated with Pruritus Reduction in Maralixibat-Treated Patients with BSEP Deficiency.
    Zhao X; Zhang W; Vig P; Kostrub C; Setchell KDR
    Metabolites; 2022 Oct; 12(10):. PubMed ID: 36295854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the placenta in serum autotaxin elevation during maternal cholestasis.
    Macias RIR; Matilla S; Lozano E; Estiú MC; Oude Elferink RP; Marin JJG
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G399-G407. PubMed ID: 29927323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestasis-Associated Pruritus and Its Pruritogens.
    Langedijk JAGM; Beuers UH; Oude Elferink RPJ
    Front Med (Lausanne); 2021; 8():639674. PubMed ID: 33791327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus.
    Hegade VS; Pechlivanis A; McDonald JAK; Rees D; Corrigan M; Hirschfield GM; Taylor-Robinson SD; Holmes E; Marchesi JR; Kendrick S; Jones DE
    Liver Int; 2019 May; 39(5):967-975. PubMed ID: 30735608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pruritus in cholestasis: facts and fiction.
    Beuers U; Kremer AE; Bolier R; Elferink RP
    Hepatology; 2014 Jul; 60(1):399-407. PubMed ID: 24807046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteroendocrine cells are a potential source of serum autotaxin in men.
    Bolier R; Tolenaars D; Kremer AE; Saris J; Parés A; Verheij J; Bosma PJ; Beuers U; Oude Elferink RPJ
    Biochim Biophys Acta; 2016 Apr; 1862(4):696-704. PubMed ID: 26775031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, tolerability, and efficacy of maralixibat in adults with primary sclerosing cholangitis: Open-label pilot study.
    Bowlus CL; Eksteen B; Cheung AC; Thorburn D; Moylan CA; Pockros PJ; Forman LM; Dorenbaum A; Hirschfield GM; Kennedy C; Jaecklin T; McKibben A; Chien E; Baek M; Vig P; Levy C
    Hepatol Commun; 2023 Jun; 7(6):. PubMed ID: 37184523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC).
    Sun Y; Zhang W; Evans JF; Floreani A; Zou Z; Nishio Y; Qi R; Leung PS; Bowlus CL; Gershwin ME
    Autoimmun Rev; 2016 Aug; 15(8):795-800. PubMed ID: 27019050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Odevixibat as an adjunctive treatment for refractory pruritus in rare variants of cholestatic liver disease.
    Goel A; Tucker B; Casale LS; Grammatikopoulos T
    JPGN Rep; 2024 Aug; 5(3):296-302. PubMed ID: 39149201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colesevelam attenuates cholestatic liver and bile duct injury in
    Fuchs CD; Paumgartner G; Mlitz V; Kunczer V; Halilbasic E; Leditznig N; Wahlström A; Ståhlman M; Thüringer A; Kashofer K; Stojakovic T; Marschall HU; Trauner M
    Gut; 2018 Sep; 67(9):1683-1691. PubMed ID: 29636383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the role of bile acids and serotonin as markers of pruritus in children with chronic cholestatic liver disease.
    Koofy NE; Yassin N; Okasha S; William H; Elakel W; Elshiwy Y
    Arab J Gastroenterol; 2021 Sep; 22(3):199-202. PubMed ID: 34090830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
    Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
    J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.